Compass Therapeutics, Inc. Quarterly Common Stock, Shares Authorized from Q1 2018 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Compass Therapeutics, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q1 2018 to Q2 2024.
  • Compass Therapeutics, Inc. Common Stock, Shares Authorized for the quarter ending June 30, 2024 was 300M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 300M 0 0% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 300M 0 0% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 300M 0 0% Dec 31, 2023 10-Q 2024-08-12
Q3 2023 300M 0 0% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 300M 0 0% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 300M 0 0% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 300M 0 0% Dec 31, 2022 10-K 2024-03-21
Q3 2022 300M 0 0% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 300M 0 0% Jun 30, 2022 10-Q 2022-08-01
Q1 2022 300M 0 0% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 300M 0 0% Dec 31, 2021 10-K 2023-03-15
Q3 2021 300M 0 0% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 300M 0 0% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 300M 0 0% Mar 31, 2021 10-Q 2021-04-30
Q4 2020 300M 0 0% Dec 31, 2020 10-K 2022-03-18
Q3 2020 300M +250M +500% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 300M +250M +500% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 300M +250M +500% Mar 31, 2020 10-K 2021-03-05
Q4 2019 300M +250M +500% Dec 31, 2019 10-K 2021-03-05
Q3 2019 50M 0 0% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 50M 0 0% Jun 30, 2019 10-Q 2019-08-13
Q1 2019 50M 0 0% Mar 31, 2019 10-K 2020-06-08
Q4 2018 50M Dec 31, 2018 10-Q 2019-02-14
Q3 2018 50M Sep 30, 2018 10-Q 2018-11-14
Q2 2018 50M Jun 30, 2018 10-Q 2018-08-14
Q1 2018 50M Mar 31, 2018 10-K 2019-07-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.